About US
Contact us
-
Roche throws HIV blindness drug Valcyte into patent poolIn the past, Roche ($RHHBY), like Big Pharma companies normally do, has done everything in its power to protect its drugValcytefrom low-cost generic competition. Now, however, the company has signed a2013/8/6
-
GlaxoSmithKline hits speed bump en route to diabetes drug approvalGlaxoSmithKline ($GSK) hit a roadblock in its bid for approval on a newdiabetesdrug. The FDA asked for a few more months to review GSK's app on albiglutide, which would compete with Novo Nordisk's ($N2013/8/6
-
Drug shortage complicates execution schedule for death penalty leader TexasWith 5 executions pending this year, Texas looking for new supply of pentobarbital The big concern when it comes todrug shortagesis whether crucial drugs are going to be available to keep patients al2013/8/5
-
India pulls another patent, this time for GSK's TykerbBoard revokes patent on salt version of cancer drug, upholds it on original API India has regularly been pulling the rug out from under Western drugmakers' intellectual property and has done it again2013/8/5
-
Merck to build biologics research facility in New Jersey where plant will closeNews comes after its reported huge earnings decline this week Merck ($MRK) says it will shutter another plant as it continues to suffer from the patent loss of blockbusterSingulair, but it intends to2013/8/2
-
Sanofi CEO can't sugar-coat 'shocking' Q2 resultsBrazilian snafu, generic competition prompt cut to earnings forecastCall it what you will: chutzpah, optimism, wishful thinking, spin-doctoring, or just plain confidence. In any case, the headline on2013/8/2
-
US scientists make chemotherapy tolerance breakthrough in miceScientists in Michigan have discovered a biological mechanism that can preserve the gastrointestinal tracts of mice after a lethal dose of chemotherapy, a discovery that could lead to better tolerance2013/8/1
-
Pfizer to pay $491m over illegal marketing probePfizer has agreed to pay $491m (£320m) to settle an investigation into illegal marketing of the drug Rapamune by Wyeth, a company it acquired in 2009. Sales staff at Wyeth allegedly encouraged2013/8/1
-
Europe probing Germany's practice of cutting break on fees to some drugmakersFor more than a year, Big Pharma players have been adamantly complaining about the tight-fisted approachGermanytakes toward approving new drugs. Its pricing agency has rejected offerings right and lef2013/7/29
-
CFDA Vice Minister Yin Li meets Minister for Jobs, Enterprise and Innovation of Ireland and Ambassador of Ireland to ChinaOn the morning of July 24, 2013, Yin Li, Vice Minister of China Food and Drug Administration (CFDA) met with the delegation led by Mr. Richard Bruton, Minister for Jobs, Enterprise and Innovation of I2013/7/29